Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.
Clinical trial NCT02455687 · UNKNOWN
Trial details
- NCT number
- NCT02455687
- Sponsor
- Hamad Medical Corporation
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2024-12-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.